Skip to content

Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm

Closing the Loop Between Glucose Sensor and Insulin Pump-developing an Algorithm

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00541515
Enrollment
38
Registered
2007-10-10
Start date
2007-10-31
Completion date
2015-09-30
Last updated
2016-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Type I

Keywords

Type 1 diabetes, Artificial pancreas, Insulin Pump

Brief summary

An open interventional data collection study in order to build a database to close the loop between glucose sensor and insulin pump. background: The ultimate goal in diabetes treatment is to develop an autonomous insulin delivery system (artificial pancreas) capable of continuous glucose sensing, thereby mimicking the physiologic function of the islet beta cells and freeing the patient from the need for constant calculations of daily insulin and carbohydrates. Several prototypes of closed-loop system have been developed in recent years, based on different types of control algorithms, to establish the connection between the sensor and the insulin pump. Current research in the formulation of this type of subcutaneous closed-loop system still faces major challenges, therefore, there is a need for further study and evaluation. Objectives: 1. To evaluate the lag time of the effect of subcutaneous insulin infusion on blood glucose levels by using continuous glucose sensor 2. To measure the insulin sensitivity as expressed by changes in blood glucose levels after s.c insulin infusion . 3. To evaluate real time sensor calibration algorithms based on the measured lag times 4. Collecting clinical data in order to develop and evaluate mathematical models which will serve a base to simulators. 5. Developing and accessing advanced learning and control algorithms as a step towards developing an artificial pancreas

Interventions

DEVICEcontinuous glucose sensors and insulin pump

continuous glucose sensors and insulin pump

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diabetes type 1 for at least one year. 2. ages \>10 years. 3. signed informed consent form. 4. willing to cooperate with all study requirements.

Exclusion criteria

1. Sensor allergy. 2. Psychiatrist diseases. 3. other chronic diseases. 4. Participation in another study that involves a medicine or a medical device.Subjects have to finish participating in other studies at least 30 days before joining this study. Each subject can participate in this study only once.

Design outcomes

Primary

MeasureTime frame
Blood glucose levelscountinuasly

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026